Lisa S M Eurelings1, Edo Richard2, Piet Eikelenboom1, Willem A van Gool1, Eric P Moll van Charante3. 1. Department of Neurology,Academic Medical Center,University of Amsterdam,Meibergdreef 9,1105 AZ,Amsterdam,the Netherlands. 2. Department of Neurology,Radboud University Medical Center,Geert Grooteplein-Zuid 10,6525 GA,Nijmegen,the Netherlands. 3. Department of General Practice,Academic Medical Center,University of Amsterdam,Meibergdreef 15,1105 AZ,Amsterdam,the Netherlands.
Abstract
BACKGROUND: Systemic low-grade inflammation has repeatedly been associated with depression in old age, but the relationship with apathy is less clear. The present study assessed whether C-reactive protein (CRP) is differentially associated with symptoms of apathy and depression. METHODS: A population-based cohort study was carried-out. At baseline and after two and four years of follow-up, CRP levels were assessed and symptoms of apathy and depression were measured using the 15-item Geriatric Depression Scale. Logistic regression analysis was used to investigate the cross-sectional and longitudinal associations of CRP with symptoms of apathy and depression. RESULTS: Two thousand forty-seven community-dwelling participants (70-78 years) without a history of cardiovascular disease or stroke were studied. A cross-sectional association was found between CRP and apathy symptoms at three time points (odds ratio (OR) per natural log unit increase in CRP: baseline visit = 1.40, 95% CI = 1.12-1.75; two-year follow-up visit = 1.62, 95% CI = 1.17-2.25; four-year follow-up visit = 1.51, 95% CI = 1.03-2.21). This did not change after adjustment for demographics and depressive symptoms, and was slightly attenuated after adjustment for cardiovascular risk factors. No cross-sectional association was found with depressive symptoms. Baseline CRP did not predict incident apathy or depressive symptoms during four years of follow-up. CONCLUSIONS: Increased CRP levels are associated with apathy symptoms but not with depressive symptoms. This suggests a differential effect of inflammation on apathy and depression. In older persons, symptoms of apathy may be a behavioral manifestation of concurrent low-grade inflammation.
BACKGROUND: Systemic low-grade inflammation has repeatedly been associated with depression in old age, but the relationship with apathy is less clear. The present study assessed whether C-reactive protein (CRP) is differentially associated with symptoms of apathy and depression. METHODS: A population-based cohort study was carried-out. At baseline and after two and four years of follow-up, CRP levels were assessed and symptoms of apathy and depression were measured using the 15-item Geriatric Depression Scale. Logistic regression analysis was used to investigate the cross-sectional and longitudinal associations of CRP with symptoms of apathy and depression. RESULTS: Two thousand forty-seven community-dwelling participants (70-78 years) without a history of cardiovascular disease or stroke were studied. A cross-sectional association was found between CRP and apathy symptoms at three time points (odds ratio (OR) per natural log unit increase in CRP: baseline visit = 1.40, 95% CI = 1.12-1.75; two-year follow-up visit = 1.62, 95% CI = 1.17-2.25; four-year follow-up visit = 1.51, 95% CI = 1.03-2.21). This did not change after adjustment for demographics and depressive symptoms, and was slightly attenuated after adjustment for cardiovascular risk factors. No cross-sectional association was found with depressive symptoms. Baseline CRP did not predict incident apathy or depressive symptoms during four years of follow-up. CONCLUSIONS: Increased CRP levels are associated with apathy symptoms but not with depressive symptoms. This suggests a differential effect of inflammation on apathy and depression. In older persons, symptoms of apathy may be a behavioral manifestation of concurrent low-grade inflammation.
Authors: Sarah R Horn; Madison M Long; Benjamin W Nelson; Nicholas B Allen; Philip A Fisher; Michelle L Byrne Journal: Brain Behav Immun Date: 2018-06-19 Impact factor: 7.217
Authors: Mirnova E Ceïde; Daniel Eguchi; Emmeline I Ayers; David W Lounsbury; Joe Verghese Journal: Int J Environ Res Public Health Date: 2022-06-16 Impact factor: 4.614
Authors: Lisa Sm Eurelings; Jan Willem van Dalen; Gerben Ter Riet; Eric P Moll van Charante; Edo Richard; Willem A van Gool; Osvaldo P Almeida; Tiago S Alexandre; Bernhard T Baune; Horst Bickel; Francesco Cacciatore; Cyrus Cooper; Ton Ajm de Craen; Jean-Marie Degryse; Mauro Di Bari; Yeda A Duarte; Liang Feng; Nicola Ferrara; Leon Flicker; Maurizio Gallucci; Antonio Guaita; Stephanie L Harrison; Mindy J Katz; Maria L Lebrão; Jason Leung; Richard B Lipton; Marta Mengoni; Tze Pin Ng; Truls Østbye; Francesco Panza; Letizia Polito; Dirk Sander; Vincenzo Solfrizzi; Holly E Syddall; Roos C van der Mast; Bert Vaes; Jean Woo; Kristine Yaffe Journal: Clin Epidemiol Date: 2018-04-04 Impact factor: 4.790
Authors: Mohammed Saied Bakeer; Mohamed Ibrahim Youssef; Helmy M Elshazly; Mohamed Abdel-Samiee; Abdelaleem A El-Gendy; M Abouzed; Warda Othman; Mervat Abdelkareem; Mai Abozeid; Samah Mohammed Awad; Fatma O Khalil; Hanan M Bedair; Karema A Diab; A S Seif; Marwa F Youssef; Ayman Ahmed Sakr; Eman Abdelsameea Journal: Infect Drug Resist Date: 2019-08-22 Impact factor: 4.003
Authors: Mirnova E Ceïde; Alana Warhit; Emmeline I Ayers; Gary Kennedy; Joe Verghese Journal: J Gerontol B Psychol Sci Soc Sci Date: 2020-08-13 Impact factor: 4.077